Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia 33Breast Neoplasms 20Leukemia, Myeloid, Acute 15Carcinoma, Non-Small-Cell Lung 14Lung Neoplasms 13Head and Neck Neoplasms 13Congenital Abnormalities 12Squamous Cell Carcinoma of Head and Neck 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma 9Kidney Neoplasms 9Central Nervous System Neoplasms 9Sarcoma 8Rectal Neoplasms 8Leukemia, Megakaryoblastic, Acute 8Colorectal Neoplasms 8Colonic Neoplasms 8Lymphoma, Follicular 7Leukemia, Myelomonocytic, Acute 7Leukemia, Monocytic, Acute 7Leukemia, Erythroblastic, Acute 7Gliosarcoma 7Glioblastoma 7Multiple Myeloma 6Melanoma 6Neuroblastoma 5Lymphoma, Large B-Cell, Diffuse 5Esophageal Neoplasms 5Carcinoma, Intraductal, Noninfiltrating 5Wilms Tumor 4

Interventions

Carboplatin 41Paclitaxel 40pembrolizumab 38Cyclophosphamide 23Gemcitabine 22130-nm albumin-bound paclitaxel 21Doxorubicin 18Cisplatin 18Albumin-Bound Paclitaxel 18atezolizumab 16Taxes 15Capecitabine 13veliparib 10Nivolumab 9Docetaxel 9Bevacizumab 9olaparib 8liposomal doxorubicin 7Everolimus 7spartalizumab 6durvalumab 6Epirubicin 6trametinib 5pegfilgrastim 5eribulin 5Irinotecan 5Filgrastim 5iniparib 4binimetinib 4apatinib 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Triple Negative Breast Neoplasms × Gene Expression Profiling × Clear all
NCT00918892 2022-08-01

Assessment of Candidate Protein Expression in Breast Cancer Specimens

Case Comprehensive Cancer Center

Completed
460 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡